Previous close | 0.00 |
Open | 41.26 |
Bid | 38.71 x 39400 |
Ask | 42.40 x 45100 |
Day's range | 41.26 - 41.26 |
52-week range | 34.91 - 53.39 |
Volume | |
Avg. volume | 3,452 |
Market cap | 51.503B |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | 41.65 |
EPS (TTM) | 0.94 |
Earnings date | 24 Oct 2024 |
Forward dividend & yield | 0.25 (0.64%) |
Ex-dividend date | 28 May 2024 |
1y target est | N/A |
NEW YORK, September 17, 2024--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix® Assessment for Electronic Data Capture (EDC) in life sciences.
LONDON, September 11, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the European Organisation for Research and Treatment of Cancer (EORTC), announced today a four-year extension to their partnership. The extended relationship will enable EORTC to further increase patient access to oncology clinical trials, make trial participation easier, and help to deliver new treatments to the market faster. EORTC is now leveragin
Press ReleaseVELIZY-VILLACOUBLAY, France — September 5, 2024 Declaration of the number of outstanding shares and voting rights as of August 31, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of August 31, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,313,330Number of voting rights*: 2,013,085,275